Oats, beta-glucan and the product that was tested.
Processing details complicate the move from a cereal trial to a breakfast bowl.

Illustrative food image, not a photograph of the study intervention.
Food form belongs in the methods.
Wolever’s trial compared formulated cereals with different beta-glucan molecular weights. The high-molecular-weight treatment reduced LDL versus a wheat-fiber cereal; the low-molecular-weight treatment did not significantly do so. A shared oat label does not make products equivalent.
Wolever TM, Tosh SM, Gibbs AL, Brand-Miller J, et al.. The American journal of clinical nutrition, 2010. PMID 20660224 · DOI
Keep the endpoint in view.
The study ran for four weeks and measured serum lipids. It did not demonstrate a survival benefit, test our breakfast or establish that a particular home preparation reproduces the trial cereal.
Wolever TM, Tosh SM, Gibbs AL, Brand-Miller J, et al.. The American journal of clinical nutrition, 2010. PMID 20660224 · DOI